Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs

World News: . []

SAN CARLOS Calif May 15 2019 GLOBE NEWSWIRE -- LINK  Biotherapeutics Inc NASDAQ IOVA a late-stage biotechnology company developing novel LINK  immunotherapies based on tumor-infiltrating lymphocyte TIL technology today announced updates...

More news and information about Iovance Biotherapeutics, Inc.

Published By:

Globe Newswire: 22:27 GMT Wednesday 15th May 2019

Published: .

Search for other references to "iovance" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us